Elanco Animal Health Incorporated is a global animal health company that develops products and services to prevent and treat disease in pets and farm animals. Headquartered in Greenfield, Indiana, Elanco was part of Eli Lilly before its 2018 IPO and 2019 spin-off. It trades on the NYSE under the ticker ELAN.